These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 38085892)

  • 1. 2021 World Health Organization Classification of Brain Tumors.
    Meredith DM; Pisapia DJ
    Continuum (Minneap Minn); 2023 Dec; 29(6):1638-1661. PubMed ID: 38085892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Updates on the WHO diagnosis of IDH-mutant glioma.
    Reuss DE
    J Neurooncol; 2023 May; 162(3):461-469. PubMed ID: 36717507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Classification and Grading of Central Nervous System Tumors According to the World Health Organization 5th Edition.
    Yoda RA; Cimino PJ
    Semin Neurol; 2023 Dec; 43(6):833-844. PubMed ID: 37949117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Evolving Classification of Diffuse Gliomas: World Health Organization Updates for 2021.
    Perez A; Huse JT
    Curr Neurol Neurosci Rep; 2021 Nov; 21(12):67. PubMed ID: 34817712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The 2021 WHO Classification of Tumors of the Central Nervous System: An update on pediatric low-grade gliomas and glioneuronal tumors.
    Bale TA; Rosenblum MK
    Brain Pathol; 2022 Jul; 32(4):e13060. PubMed ID: 35218102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The 2021 WHO Classification of Tumors, 5th edition, Central Nervous System Tumors: A Short Review].
    Komori T
    Brain Nerve; 2022 Jun; 74(6):803-809. PubMed ID: 35676215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The 2021 WHO classification of tumours of the central nervous system].
    Figarella-Branger D; Appay R; Metais A; Tauziède-Espariat A; Colin C; Rousseau A; Varlet P
    Ann Pathol; 2022 Oct; 42(5):367-382. PubMed ID: 34865882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [World Health Organization Classification of Central Nervous System Tumours, 5
    Ichimura K
    No Shinkei Geka; 2023 Mar; 51(2):349-363. PubMed ID: 37055056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Laboratory Testing Practices in Diffuse Gliomas Prior to Publication of 2021 World Health Organization Classification of Central Nervous System Tumors.
    Ramkissoon SH; Fernandes H; Lopez-Terrada DH; Hameed MR; Trembath DG; Bridge JA; Lindeman NI; Souers RJ; Vasalos P; Brat DJ; Moncur JT
    Arch Pathol Lab Med; 2022 May; 147(5):518-524. PubMed ID: 35878398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review of adult-type diffuse gliomas in the WHO CNS5 classification with special reference to Astrocytoma, IDH-mutant and Oligodendroglioma, IDH-mutant and 1p/19q codeleted.
    Santosh V; Rao S
    Indian J Pathol Microbiol; 2022 May; 65(Supplement):S14-S23. PubMed ID: 35562130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic, therapeutic, and prognostic implications of the 2021 World Health Organization classification of tumors of the central nervous system.
    Gritsch S; Batchelor TT; Gonzalez Castro LN
    Cancer; 2022 Jan; 128(1):47-58. PubMed ID: 34633681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2021 updates to the World Health Organization classification of adult-type and pediatric-type diffuse gliomas: a clinical practice review.
    Thomas DL
    Chin Clin Oncol; 2023 Feb; 12(1):7. PubMed ID: 36922356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular diagnostic tools for the World Health Organization (WHO) 2021 classification of gliomas, glioneuronal and neuronal tumors; an EANO guideline.
    Sahm F; Brandner S; Bertero L; Capper D; French PJ; Figarella-Branger D; Giangaspero F; Haberler C; Hegi ME; Kristensen BW; Kurian KM; Preusser M; Tops BBJ; van den Bent M; Wick W; Reifenberger G; Wesseling P
    Neuro Oncol; 2023 Oct; 25(10):1731-1749. PubMed ID: 37279174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical impact of revisions to the WHO classification of diffuse gliomas and associated future problems.
    Sonoda Y
    Int J Clin Oncol; 2020 Jun; 25(6):1004-1009. PubMed ID: 32020379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review of the Recent Changes in the WHO Classification for Pediatric Brain and Spinal Cord Tumors.
    Halfpenny AM; Wood MD
    Pediatr Neurosurg; 2023; 58(5):337-355. PubMed ID: 36617415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Miscellaneous newly recognized types of CNS tumors in the WHO CNS5 classification (other than gliomas, glioneuronal and embryonal tumors).
    Chatterjee D; Gupta K
    Indian J Pathol Microbiol; 2022 May; 65(Supplement):S94-S98. PubMed ID: 35562139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The 2016 revision of the WHO Classification of Central Nervous System Tumours: retrospective application to a cohort of diffuse gliomas.
    Rogers TW; Toor G; Drummond K; Love C; Field K; Asher R; Tsui A; Buckland M; Gonzales M
    J Neurooncol; 2018 Mar; 137(1):181-189. PubMed ID: 29218432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. WHO 2021 and beyond: new types, molecular markers and tools for brain tumor classification.
    Tran S; Bielle F
    Curr Opin Oncol; 2022 Nov; 34(6):670-675. PubMed ID: 36093875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes to pediatric brain tumors in 2021 World Health Organization classification of tumors of the central nervous system.
    Oztek MA; Noda SM; Romberg EK; Cole BL; Wright JN; Ishak GE; Perez FA
    Pediatr Radiol; 2023 Mar; 53(3):523-543. PubMed ID: 36348014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrated diagnostics of diffuse astrocytic and oligodendroglial tumors.
    Malzkorn B; Reifenberger G
    Pathologe; 2019 Jun; 40(Suppl 1):9-17. PubMed ID: 31025086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.